HOUSE 2297118th CongressReferred to the Subcommittee on Health.

To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024.

Last Action: 4/7/2023

Actions

2023-04-07Referred to the Subcommittee on Health.
2023-03-29Referred to the House Committee on Energy and Commerce.
2023-03-29Introduced in House
2023-03-29Introduced in House

CRS Summary

As of 2023-03-29 (00)

This bill limits FY2024 funding for the Food and Drug Administration (FDA) Innovation Account, which the FDA uses to implement provisions of the 21st Century Cures Act relating to the development of medical products.

Cosponsors (5)

Matthew Rosendale (R-MT)
Matt Gaetz (R-FL)
Bob Good (R-VA)
Chip Roy (R-TX)
Elijah Crane (R-AZ)

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.